Schnell Biopharmaceuticals, Inc. (003060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Schnell Biopharmaceuticals, Inc. (003060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Schnell Biopharmaceuticals, Inc. (003060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Schnell Biopharmaceuticals, Inc. (003060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
34 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Schnell Biopharmaceuticals, Inc. (Schnell) is a manufacturer of pharmaceutical products. The company provides pharmaceutical products including amino acid infusion agents and antibiotics. Its products portfolio includes antibiotics, infusions, containing amino acid, vitamin and hepatic protect infusions; gastrointestinal agents, comprising of digestives and antiulcerants; musculoskeletal system agents, consisting of anti-inflammatory drugs, muscle relaxants, respiratory system agents, including expectorants, antitussives and antihistamines. Schnell also produces vitamins and nutrition agents. The company provides the other drugs such as antiemetics and antineoplastic agents.

Schnell Biopharmaceuticals, Inc. (003060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which

  
Source:
Document ID
GDPH81979D
Industry
Ticker
003060=KR
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Schnell Biopharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Schnell Biopharmaceuticals, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Schnell Biopharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Schnell Biopharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201682
Schnell Biopharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
Schnell Biopharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deal Details1219
  Partnerships121
    Binex Forms Joint Venture with Aprogen121
    Schnell BioPharma Enters Into Co-Development Agreement With Aprogen And Chunggei Pharm131
  Licensing Agreements141
    Schnell BioPharma Enters Into Licensing Agreement With Aquapick141
    Schnell BioPharma Enters Into Licensing Agreement With AVVA151
  Equity Offering161
    Schnell BioPharma Completes Private Placement Of US$3.3 Million162
    Schnell BioPharma Completes Rights Offering Of Common Stock For US$3.6 Million181
  Debt Offering191
    Schnell Biopharma to Raise USD10 Million in Public Offering of 2% Bonds Due 2019191
    Schnell Biopharma to Raise USD9.2 Million in Public Offering of 2% Bonds Due 2019201
    Schnell BioPharma Completes Issue Of Ninth Unsecured Bonds Due 2014 For US$8.8 Million211
    Schnell BioPharma Completes Issue Of Eighth Unsecured Bonds Due 2014 For US$14.5 Million221
    Schnell BioPharma Completes Offering Of Seventh Unsecured Bonds Due 2013 For US$8.48 Million231
  Acquisition241
    Huacheng Travel Agency Plans to Acquire Schnell Biopharma241
    Gbase to Acquire 22% Stake in Aprogen for USD16 Million251
    Binex Completes Acquisition of 22% Stake in Aprogen for USD14 million262
    Schnell Biopharma Sells 50% Stake In CHUNG GEI Pharma For US$6.5 Million281
    Nichi-iko Pharma Acquires 33.4% Stake In Aprogen291
    Schnell BioPharma Acquires Remaining 39% Stake In Chunggei Pharm301
Schnell Biopharmaceuticals, Inc. - Key Competitors311
Key Employees321
Locations And Subsidiaries331
  Head Office331
  Other Locations &Subsidiaries331
Appendix341
  Methodology341
  About GlobalData341
  Contact Us341
  Disclaimer341

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Schnell Biopharmaceuticals, Inc. (003060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Schnell-Biopharmaceuticals-Inc-003060-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7613>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Schnell Biopharmaceuticals, Inc. (003060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Schnell-Biopharmaceuticals-Inc-003060-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7613>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research